The Brian Lehrer Show Opioid Overdose Deaths See Sharp Decline
Mar 25, 2026
Michael McRae, StartCare leader focused on local harm reduction and racial equity. Lev Facher, data-driven addiction reporter at STAT News. They discuss the recent drop in opioid overdose deaths. They explore racial disparities, the pandemic’s role, policy versus market forces, China's precursor crackdown, rising stimulant and polysubstance deaths, and lifesaving treatments like buprenorphine and naloxone.
AI Snips
Chapters
Transcript
Episode notes
Decline In Overdose Deaths Back To Pre-COVID Levels
- U.S. opioid overdose deaths fell from ~110,000 peak to about 70,000, returning to pre-COVID levels.
- Decline began mid-2023 and continued through April 2025, driven by multiple interacting factors not a single cause.
Pandemic Disconnection Amplified Overdose Surge
- The pandemic amplified overdose deaths by disconnecting people from care and from companions who could reverse overdoses.
- Fentanyl already dominated the market so isolation and reduced services created a perfect storm in 2020–2023.
Scale Medications And Naloxone As Lifesaving Tools
- Expand access to medications for opioid use disorder and naloxone because they reduce mortality and save lives.
- Lev Facher cautions these policies alone likely don't explain the whole drop but remain critical life-saving tools.